We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
+65.96%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$35M
AUM Growth
+$5.72M
Cap. Flow
-$1.49M
Cap. Flow %
-4.24%
Top 10 Hldgs %
100%
Holding
13
New
1
Increased
5
Reduced
1
Closed
3

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$259K
2
GARS
Garrison Capital Inc.
GARS
+$135K
3
ICMB icon
Investcorp Credit Management BDC
ICMB
+$103K
4
TMH
Team Health Holdings Inc
TMH
+$7.17K
5
CDTX
Cidara Therapeutics
CDTX
+$3.86K

Top Sells

Rank Stock Value
1
AGRX
Agile Therapeutics
AGRX
+$1.26M
2
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$338K
3
ACSF
American Capital Senior Floating, Ltd.
ACSF
+$213K
4
SCM icon
Stellus Capital Investment Corp
SCM
+$188K

Sector Composition

Rank Sector Weight
1 Healthcare 75.56%
2 Financials 5.8%
3 Consumer Discretionary 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBBP
1
DELISTED
Strongbridge Biopharma plc.
SBBP
$25.6M 73.15%
5,394,994
– –
AGRX
2
DELISTED
Agile Therapeutics
AGRX
$5.2M 14.85%
812
-250
-24% -$1.26M
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.49M 4.26%
8,945
– –
GARS
4
DELISTED
Garrison Capital Inc.
GARS
$646K 1.84%
66,073
+13,945
+27% +$135K
ICMB icon
5
Investcorp Credit Management BDC
ICMB
$12.4M
$540K 1.54%
53,576
+10,520
+24% +$103K
ACRS icon
6
Aclaris Therapeutics
ACRS
$749M
$395K 1.13%
13,263
+22
+0.2% +$634
ADNT icon
7
Adient
ADNT
$1.62B
$344K 0.98%
4,737
– –
TMH
8
DELISTED
Team Health Holdings Inc
TMH
$336K 0.96%
7,713
+165
+2% +$7.17K
JAZZ icon
9
Jazz Pharmaceuticals
JAZZ
$15.2B
$289K 0.82%
+1,992
New +$259K
CDTX
10
DELISTED
Cidara Therapeutics
CDTX
$162K 0.46%
1,040
+22
+2% +$3.86K
SCM icon
11
Stellus Capital Investment Corp
SCM
$243M
– –
-15,593
Closed -$188K
PRTK
12
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-21,923
Closed -$338K
ACSF
13
DELISTED
American Capital Senior Floating, Ltd.
ACSF
– –
-17,931
Closed -$213K

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q1 2017 Portfolio in Review

As of Q1 2017, Caxton Corporation held 13 positions worth $35M, up 20% from $29.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Caxton Corporation withdrew a net $1.49M in Q1 2017, closing 3 positions and reducing 1 holding. Its most notable exit was Paratek Pharmaceuticals, Inc., an estimated $338K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, up from 47% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Caxton Corporation opened a new position in Jazz Pharmaceuticals worth $289K.

  • Caxton Corporation's largest Q1 2017 buy was Jazz Pharmaceuticals: 1,992 shares worth $289K.
  • Caxton Corporation added most to Garrison Capital Inc. in Q1 2017, an estimated $135K increase.
  • Caxton Corporation's biggest Q1 2017 reduction was Agile Therapeutics, cutting an estimated $1.26M.
  • Caxton Corporation fully exited Paratek Pharmaceuticals, Inc. in Q1 2017, selling an estimated $338K.
  • Caxton Corporation's ten largest holdings make up 100% of its $35M portfolio in Q1 2017.
  • Caxton Corporation opened 1 new position and closed 3 in Q1 2017.
  • Caxton Corporation's portfolio value rose 20% quarter-over-quarter to $35M.

Based on Caxton Corporation's 13F filing for Q1 2017, filed 15 May 2017.